Texas, 36 States Reach $181 Million Settlement With Janssen Pharmaceuticals

Texas Attorney General Greg Abbott, along with attorneys general from 36 other states, announced a $181 million dollar settlement with Janssen Pharmaceuticals. The settlement follows a four-year investigation of unlawful and deceptive marketing of antipsychotic drugs.

The investigation revealed the Johnson & Johnson subsidiary urged physicians to prescribe Risperdal and other antipsychotic drugs for treatment of Alzheimer’s disease, dementia, depression, and anxiety. The U.S. Food and Drug Administration has approved Risperdal-related drugs only for the treatment of schizophrenia.

Tom Kelley is a spokesman for the Texas Attorney General’s Office.

“Physicians may or may not have decided to prescribe these drugs this way. That’s the physicians’ call. What a company may not do itself is to urge physicians to prescribe in an off-label manner — it’s called off-label marketing — and that’s exactly what was going on here.”

Texas will receive just over $11 million under the settlement. Earlier this year, the attorney general’s office resolved a similar case against Janssen involving Medicaid fraud. The latest agreement covers misrepresentations made to doctors of non-Medicaid patients.


Andrew Schneider

Andrew Schneider

Business Reporter

Andrew Schneider joined News 88.7 in January 2011. Since arriving in Houston, he has reported on the many changes wrought on the region’s economy by the revolution in domestic oil and gas production. His non-energy reporting runs the gamut from white-collar crime to cattle ranching. His work has aired on...

More Information